Related references
Note: Only part of the references are listed.Lactulose therapy for patients with cirrhosis, portal hypertension, and poor patient-reported outcomes: The Mi-Kristal trial
Elliot B. Tapper et al.
HEPATOLOGY (2023)
Combined PEG3350 Plus Lactulose Results in Early Resolution of Hepatic Encephalopathy and Improved 28-Day Survival in Acute-on-Chronic Liver Failure
Syed Ahmed et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2022)
Bristol Stool Scale as a Determinant of Hepatic Encephalopathy Management in Patients With Cirrhosis
Nikki K. Duong et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)
Bowel Movement Frequency Is Not Linked With Cognitive Function in Cirrhosis
Nikki Duong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Co-Administration of Lactulose Crystals with Amoxicillin Followed by Prolonged Lactulose Treatment Promotes Recovery of the Human Gut Microbiome In Vitro
Cindy Duysburgh et al.
ANTIBIOTICS-BASEL (2022)
Targeting the gut-liver-immune axis to treat cirrhosis
Thomas Henry Tranah et al.
GUT (2021)
Factors associated with health-related quality of life in patients with cirrhosis: a systematic review
Anahita Rabiee et al.
LIVER INTERNATIONAL (2021)
Development and Validation of Test for Leaky Gut Small Intestinal and Colonic Permeability Using Sugars in Healthy Adults
Katayoun Khoshbin et al.
GASTROENTEROLOGY (2021)
Selective Isolation of Bifidobacterium From Human Faeces Using Pangenomics, Metagenomics, and Enzymology
Shuanghong Yang et al.
FRONTIERS IN MICROBIOLOGY (2021)
Microbiome therapeutics for hepatic encephalopathy
Patricia P. Bloom et al.
JOURNAL OF HEPATOLOGY (2021)
Comparative Efficacy of Treatment Options for Minimal Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis
Radha K. Dhiman et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Outcomes after hepatic encephalopathy in population-based cohorts of patients with cirrhosis
Elliot B. Tapper et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Tu1693 LACTULOSE WITHDRAWAL CAN POTENTIATE BREAKTHROUGH OVERT HEPATIC ENCEPHALOPATHY IN PATIENTS CONTROLLED WITH RIFAXIMIN PLUS LACTULOSE THERAPY: A POST HOC ANALYSIS OF A RANDOMIZED CONTROLLED TRIAL
Jasmohan S. Bajaj et al.
GASTROENTEROLOGY (2020)
Cognitive Tests and Stool Frequency at Hospital Discharge Do Not Predict Outcomes in Hepatic Encephalopathy
Patricia P. Bloom et al.
SOUTHERN MEDICAL JOURNAL (2020)
Probiotics and prebiotics in intestinal health and disease: from biology to the clinic
Mary Ellen Sanders et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial
Ji Yao Wang et al.
JOURNAL OF DIGESTIVE DISEASES (2019)
Best practices for analysing microbiomes
Rob Knight et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics
Janina A. Krumbeck et al.
MICROBIOME (2018)
Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease
C. A. Woodhouse et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Characterizing microbiota-independent effects of oligosaccharides on intestinal epithelial cells: insight into the role of structure and size
Peyman Akbari et al.
EUROPEAN JOURNAL OF NUTRITION (2017)
Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy
Alba Moratalla et al.
LIVER INTERNATIONAL (2017)
Targeting the gut-liver axis in liver disease
Reiner Wiest et al.
JOURNAL OF HEPATOLOGY (2017)
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics
Glenn R. Gibson et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration
Aditya Narayan Sarangi et al.
BMC GASTROENTEROLOGY (2017)
Lipopolysaccharide biogenesis and transport at the outer membrane of Gram-negative bacteria
Paola Sperandeo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2017)
Hepatic Encephalopathy Is Associated With Mortality in Patients With Cirrhosis Independent of Other Extrahepatic Organ Failures
Jasmohan S. Bajaj et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
A Quality Improvement Initiative Reduces 30-Day Rate of Readmission for Patients With Cirrhosis
Elliot B. Tapper et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Galacto-oligosaccharides may directly enhance intestinal barrier function through the modulation of goblet cells
Shikha Bhatia et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2015)
Large intestine permeability is increased in patients with compensated liver cirrhosis
Kirsten E. Pijls et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver
Hendrik Vilstrup et al.
HEPATOLOGY (2014)
Effects of lactulose supplementation on performance, blood profiles, excreta microbial shedding of Lactobacillus and Escherichia coli, relative organ weight and excreta noxious gas contents in broilers
J. H. Cho et al.
JOURNAL OF ANIMAL PHYSIOLOGY AND ANIMAL NUTRITION (2014)
Lactulose vs Polyethylene Glycol 3350-Electrolyte Solution for Treatment of Overt Hepatic Encephalopathy The HELP Randomized Clinical Trial
Robert S. Rahimi et al.
JAMA INTERNAL MEDICINE (2014)
In Vitro Fermentation of Lactulose-Derived Oligosaccharides by Mixed Fecal Microbiota
Alejandra Cardelle-Cobas et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2012)
Techniques used to characterize the gut microbiota: a guide for the clinician
Marianne H. Fraher et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy
Jasmohan S. Bajaj et al.
METABOLIC BRAIN DISEASE (2012)
A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy
Vibhu Vibhas Mittal et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2011)
Enteric Dysbiosis Associated with a Mouse Model of Alcoholic Liver Disease
Arthur W. Yan et al.
HEPATOLOGY (2011)
Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients
J. S. Bajaj et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Rifaximin Treatment in Hepatic Encephalopathy
Nathan M. Bass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Secondary Prophylaxis of Hepatic Encephalopathy: An Open-Label Randomized Controlled Trial of Lactulose Versus Placebo
Barjesh Chander Sharma et al.
GASTROENTEROLOGY (2009)
Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy
Srinivasa Prasad et al.
HEPATOLOGY (2007)
Endotoxemia produces coma and brain swelling in bile duct ligated rats
Gavin Wright et al.
HEPATOLOGY (2007)
Prospective, randomized, parallel-group trial to evaluate the effects of lactulose and polyethylene glycol-4000 on colonic flora in chronic idiopathic constipation
Y Bouhnik et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Lactulose ingestion increases faecal bifidobacterial counts:: A randomised double-blind study in healthy humans
Y Bouhnik et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2004)
Application of prebiotics and probiotics in poultry production
JA Patterson et al.
POULTRY SCIENCE (2003)
Share Paper
